Skip to main content
. 2021 Feb 26;6(6):1661–1668. doi: 10.1016/j.ekir.2021.02.018

Table 3.

Comparison of patients who achieved remission with those who failed to achieve remission

Characteristic Remission (n = 53) No remission (n = 43) OR (95% CI) P
Age (yr), mean ± SD 31.9 ± 9.3 34.9 ± 11.1 1.03(0.99–1.07) 0.149
Male sex (%) 43 (81.1) 31 (72.1) 1.67 (0.64–4.12) 0.335
Hypertension (%) 28 (52.8) 28 (65.1) 0.6 (0.26–1.35) 0.298
BMI, mean ± SD 23.5 ± 5.0 23.7 ± 4.2 1.02 (0.98–1.05) 0.821
Systolic BP (mm Hg), mean ± SD 133.4 ± 11.9 135.3 ± 10.5 1.02 (0.98–1.05) 0.398
Diastolic BP (mm Hg), mean ± SD 83.9 ± 7.5 84.2 ± 7.6 1.01 (0.95–1.06) 0.840
MAP (mm Hg), mean ± SD 100.4 ± 8.3 101.3 ± 8.1 1.01 (0.96–1.06) 0.609
Serum creatinine (mg/dl), mean ± SD 1.2 ± 0.4 1.5 ± 0.5 3.63 (1.42–9.24) 0.007
eGFR (ml/min per 1.73 m2), mean ± SD 83.3 ± 31.3 62.5 ± 26.6 0.98 (0.96–0 .99) 0.002
eGFR < 50 ml/min per 1.73 m2 (%) 9 (17.0) 16 (37.2) 2.90 (1.16–7.10) 0.035
Hematuria (%) 27 (50.9) 25 (58.1) 1.34 (0.59–3.01) 0.482
24-h Urinary protein:creatinine ratio, mean ± SD 2.4 ± 1.1 2.9 ± 1.2 1.40 (0.97–2.02) 0.076
Serum albumin (mg/dl), mean ± SD 4.3 ± 0.6 3.7 ± 0.6 0.16 (0.07–0.38) <0.001
Serum cholesterol (mg/dl), mean ± SD 185.9 ± 43.9 192.5 ± 60.8 1.00 (0.99–1.01) 0.538
Serum uric acid (mg/dl), mean ± SD 6.9 ± 2.0 7.2 ± 1.9 1.08 (0.88–1.34) 0.459
M1 42 (79.3) 34 (79.1) 0.99 (0.37–2.66) 0.983
E1 1 (1.9) 6 (14.0) 8.43 (0.97–3.01) 0.053
S1 39 (73.6) 37 (86.1) 2.21 (0.77–6.37) 0.141
T1/2 10 (18.9) 19 (44.2) 3.40 (1.36–8.49) 0.009
C1 3 (5.7) 6 (14.0) 2.7 (0.6–11.52) 0.179
Need for additional antihypertensives 27 (50.9) 27 (62.8) 1.63 (0.72–3.69) 0.246
Rx with statin 12 (23.1) 14 (35.9) 1.87 (0.74–4.68) 0.183
Rx for hyperuricemia 15 (28.3) 29 (69.1) 5.65 (2.33–13.71) <0.001

BMI, body mass index; BP, blood pressure; CI, confidence interval; eGFR, estimated glomerular filtration rate; MAP, mean arterial pressure; OR, odds ratio; Rx, prescription.